MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ZAKRZEWSKI, S. F.
Right arrow Articles by NICHOL, C. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by ZAKRZEWSKI, S. F.
Right arrow Articles by NICHOL, C. A.

Molecular Pharmacology, Vol 2, 423-431, Copyright © 1966 by the American Society for Pharmacology and Experimental Therapeutics

Purification and Properties of Folate Reductase, the Cellular Receptor of Amethopterin

SIGMUND F. ZAKRZEWSKI 1, MAIRE T. HAKALA 1, and CHARLES A. NICHOL 1

1 Department of Experimental Therapeutics, Roswell Park Memorial Institute, New York State Department of Health, Buffalo, New York 14203

Folate reductase has been purified from an amethopterin-resistant subline of cultured Sarcoma-180 cells. The molecular weight of this enzyme was estimated to be 21,000. The specific activity of the purified reductase was 3.1 x 10-8 mole of the enzyme per milligram of protein, and on this basis the preparation was calculated to be 65% pure. During free boundary electrophoresis, however, the enzyme migrates as a single peak toward the anode at pH 8.7. Both folate and dihydrofolate are substrates for this reductase, dihydrofolate being reduced much faster than folate at 30°. The Michaelis constant (Km) and the turnover number with dihydrofolate as substrate are independent of pH between pH 4.5 and 6.3. When folate is the substrate, both Km and the turnover number decrease with increasing pH. The enthalpy of activation is +14.7 kcal for dihydrofolate and +5.7 kcal for folate. The properties of the reductase of Sarcoma-180 are compared with those of other preparations of this enzyme from different sources.

Note:
ACKNOWLEDGMENT The authors are indebted to Dr. Peter Stelos for performing the free boundary electrophoresis and to Mrs. Jadwiga Drobniak and Mrs. Marcia Berggren for their capable technical assistance. This investigation was supported in part by research grants (CA-02906 and CA-04175) from the National Cancer Institute of the United States Public Health Service.

Submitted on May 2, 1966







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1966 by the American Society for Pharmacology and Experimental Therapeutics